Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01936675 · ClinicalTrials.gov registry record · NA
Myocardial Infarction Genes (MI-GENES) Study
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 216
- Enrollment target
NCT01936675: Completed NA study, sponsored by Mayo Clinic.
NCT01936675 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 216 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01936675, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 216 participants
- Enrollment target
Study Summary
This study is being done to better understand how genetic information might improve assessment of heart attack risk.
Interventions
- OTHER Genetic Risk Score
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-11 |
| Phase | NA |
What the finished NCT01936675 record still lists
NCT01936675 is an interventional study that assigns participants to a tested intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which Genetic Risk Score is the first listed.
NCT01936675 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01936675 about?
NCT01936675 is a clinical study titled "Myocardial Infarction Genes (MI-GENES) Study". This study is being done to better understand how genetic information might improve assessment of heart attack risk.
What is the current status of trial NCT01936675?
This trial is currently completed. It is a NA study. The enrollment target is 216 participants. The study started on 2013-07. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01936675?
The interventions under investigation include: Genetic Risk Score (OTHER).
Who is sponsoring clinical trial NCT01936675?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01936675's enrollment target sits among peer trials
216 485th of 2000 higher than 1,514 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02609685 · 216 participants · NA
Active Surveillance of Papillary Thyroid Microcarcinoma
- NCT04994873 · 216 participants · NA
Skills to Enhance Positivity in Suicidal Youth
- NCT05264779 · 216 participants · NA
The Periviable GOALS Decision Support Tool
- NCT05434130 · 216 participants · Phase 2
Modulating Exercise Dosage to Improve Concussion Recovery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia